leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 02:29:50 - browse：725

Susan Tousi is leaving Illumina to become CEO of cancer liquid-biopsy startup Delfi. Nasdaq

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed Susan Tousi, chief commercial officer for genomics giant Illumina, as its new CEO. She is the fourth senior executive to leave Illumina since June.

Tousi will start next week, just in time for the J.P. Morgan Healthcare Conference, while founding CEO Victor Velculescu will remain on the company’s board to help guide its research programs. Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and build on the initial launch of its lung cancer screening test last fall, the latest example of growing interest in the vast and increasingly competitive liquid biopsy market.

Illumina’s own ambitions to enter this space recently came undone after a prolonged battle with U.S. and European regulators finally pushed the company to announce last month that it would divest Grail, which it had acquired for $8 billion two years earlier. Bas Verhoef, Illumina’s head of region for Europe, will serve as interim chief commercial officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The PBM ad wars are taking over Washington, D.C.

WSS

STAT's guide to the next generation of CAR

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Do masks work? RCTs can't tell us

What to know about a major upcoming Wegovy heart health study

focus

leisure time

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

3 hurdles to bringing medical devices to the U.S. market

Guidelines to prevent youth baseball injuries need more muscle

The story of mRNA: From a loose idea to a tool that may help curb Covid

The high cost of giving birth even with insurance

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

House panel to mark up pandemic

Wildfire smoke exposes gaps in outdoor worker protections

Paxlovid study fails to answer questions over benefit for broader groups

hotspot

North Korean leader's powerful sister says warplanes repelled US spy plane

UPS workers' union leader explains what's at stake as strike edges closer

Another man arrested in connection with shooting at Kansas nightclub

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Titanic submersible: What a 'catastrophic implosion' means and what officials found

3 hurdles to bringing medical devices to the U.S. market

focus

focus

hotspot

Wikipedia